scholarly journals SP313INCIDENCE AND DETERMINANTS OF HYPERKALEMIA IN A LARGE NORTH EUROPEAN HEALTHCARE SYSTEM

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii212-iii212
Author(s):  
Erik Nilsson ◽  
Alessandro Gasparini ◽  
Johan Ärnlöv ◽  
Hairong Xu ◽  
Karin Henriksson ◽  
...  
Author(s):  
Z. Kovacs ◽  
R. McClatchey ◽  
T. Solomonides ◽  
J.-M. Le Goff ◽  
P. Lecoq ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (4) ◽  
pp. e045590
Author(s):  
Niall Patrick Connolly ◽  
Andrew Simpkin ◽  
Darren Mylotte ◽  
James Crowley ◽  
Stephen O'Connor ◽  
...  

AimsTo evaluate temporal trends of acute coronary syndromes (ACS) treated via percutaneous coronary intervention (PCI) throughout the COVID-19 outbreak in a European healthcare system affected but not overwhelmed by COVID-19-related pathology.Methods and resultsWe performed a retrospective multicentre analysis of the rates of PCI for the treatment of ACS within the period 2 months pre and post the first confirmed COVID-19 case in Ireland, as well as comparing PCI for ST-elevation myocardial infarction (STEMI) with the corresponding period in 2019. During the 2020 COVID-19 period (29 February–30 April 2020), there was a 24% decline in PCI for overall ACS (incidence rate ratio (IRR) 0.76; 95% CI 0.65 to 0.88; p<0.001), including a 29% reduction in PCI for non-ST-elevation ACS (IRR 0.71; 95% CI 0.57 to 0.88; p=0.002) and an 18% reduction in PCI for STEMI (IRR 0.82; 95% CI 0.67 to 1.01; p=0.061), as compared with the 2020 pre-COVID-19 period (1 January–28 February 2020). A 22% (IRR 0.78; 95% CI 0.65 to 0.93; p=0.005) reduction of PCI for STEMI was seen as compared with the 2019 reference period.ConclusionThis study demonstrates a significant reduction in PCI procedures for the treatment of ACS since the COVID-19 outbreak in Ireland. The reasons for this decline are still unclear but patients need to be encouraged to seek medical attention when cardiac symptoms appear, in order to avoid incremental cardiac morbidity and mortality due to a reduction in coronary revascularisation for the treatment of ACS.


2021 ◽  
Vol 4 ◽  
pp. 100099
Author(s):  
Przemyslaw Kardas ◽  
Job Frank Martien van Boven ◽  
Hilary Pinnock ◽  
Enrica Menditto ◽  
Björn Wettermark ◽  
...  

2012 ◽  
Vol 3 (4) ◽  
pp. 229-238
Author(s):  
Stanka Setnikar Cankar ◽  
Veronika Petkovsek

This paper focuses improving the Slovenian healthcare system by comparing it with the systems in place in the UK, Denmark, and France. The aim of the paper is to find and present the solutions required if the healthcare system in Slovenia is to be improved. Changes need to be made to the organisation, management, and financing of the Slovenian healthcare system in response to demographic changes and changes to the age structure of the population, the rapid development of new medical technologies, drugs, treatments, and globalisation. The paper outlines the main features of the Slovenian healthcare system and compares the structure of public and private expenditure and resources with the structures in place in the UK, Denmark, and France. Public and private healthcare providers and public-private partnerships in Slovenian healthcare are also presented and compared. An insight is given at the end of the paper into the current state of the Slovenian healthcare system and the required changes, with solutions proposed for improvements and reform. The proposed solutions include redefinition of an insured person’s status, changes to the insurance basis and rates, a redefinition of the basic basket of healthcare rights, the integration and networking of public healthcare institutions, and the separation of public and private healthcare providers. 


Sign in / Sign up

Export Citation Format

Share Document